Alcobra Announces Second Quarter Financial Results and Provides Corporate Update
11 août 2014 07h00 HE
|
Alcobra Ltd.
Company Describes New Brain Imaging Data Supporting Use of MDX in ADHD
Company Reviews Patients Demographics in Phase III study
Conference Call & Webcast at 8:30 a.m. Eastern...
Alcobra Releases New Neuroimaging Data Supporting Pro-Cognitive Effects of MDX
08 août 2014 08h41 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 8, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Provide Corporate Overview at the Canaccord Genuity 34th Annual Growth Conference
06 août 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Release Second Quarter 2014 Results and Host Investor Conference Call and Webcast on Monday, August 11
01 août 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, Aug. 1, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Discusses New Market Research and Updates on Recent Corporate Events at Investor Forum in New York City
17 juil. 2014 08h12 HE
|
Alcobra Ltd.
TEL AVIV, Israel, July 17, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Completes Patient Recruitment in Phase III Clinical Trial of MDX in Adult ADHD
14 juil. 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, July 14, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra to Host Investor Forum and Webcast on July 15 in New York City
07 juil. 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, July 7, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Provide Corporate Overview at the JMP Securities Healthcare Conference
17 juin 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, June 17, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra to Present at the American Society of Clinical Psychopharmacology Annual Meeting and the BIO International Convention
09 juin 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, June 9, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company focused on the development of new medications to help patients with cognitive...
Alcobra Ltd. to Provide Corporate Overview at the Jefferies 2014 Global Healthcare Conference
27 mai 2014 08h00 HE
|
Alcobra Ltd.
TEL AVIV, Israel, May 27, 2014 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging biopharmaceutical company focused on the development of new medications to help patients with cognitive...